Skip to content
Open access

Lipoprotein(a) and statin indications in low-risk patients based on the 2026 ACC/AHA dyslipidemia guideline

Oct 2026 · American Heart Journal Plus: Cardiology Research and Practice · Vol 72 · 0 citations · 14 references
Medicine

Abstract

Background Though elevated lipoprotein (a) (Lp[a]) is associated with ASCVD and testing is recommended for all adults, how to use Lp(a) for decision-making in low-risk patients remains uncertain. Methods We studied low-risk adults in a large healthcare system, excluding those on statins or with statin indications in the 2026 ACC/AHA dyslipidemia guideline. ASCVD risk and statin eligibility were estimated using the PREVENT equations, incorporating Lp(a) using a calculation proposed by the AHA: ASCVD risk x (1.11^[(Lp[a] in nmol/L)/50]). Measured Lp(a) was used when available, and imputed values were used for all other adults. Results The cohort included 124 low-risk patients with measured Lp(a) (median [25th–75th percentile] age 44 [38–50] years; 64.5% women) and 28,527 without Lp(a) (median age 42 [36–49] years, 73.3% women). Adding Lp(a) to 10-year risk equations made 3.3% of patients with measured Lp(a) ≥125 nmol/L and 0.1% with imputed Lp(a) of 125 nmol/L newly statin eligible. Eligibility rose with older age, higher Lp(a), and higher ASCVD risk. When Lp(a) was added to 30-year risk in exploratory analyses, 20.2% with measured Lp(a) and 19.6% with imputed Lp(a) of 125 nmol/L met statin eligibility, and 70.0–84.6% (measured cohort) and 33.1–54.2% (imputed cohort) at the highest Lp(a) quintile met eligibility as age increased. Conclusions Integrating Lp(a) into ASCVD risk equations changes predicted risk and potential statin eligibility in low-risk adults not indicated for therapy under current guidelines. Including Lp(a) in risk estimation and clinical decision-making, particularly for patients with elevated levels, could be considered in patients with low ASCVD risk.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.